Essex Savings Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Essex Savings Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208K	Buy	+1,312	New	+$177K	0.04%	308
2025 Q2	–	Sell	-2,888	Closed	-$234K	–	321
2025 Q1	$234K	Buy	2,888 +500	+21%	+$44.7K	0.06%	259
2024 Q4	$215K	Hold	2,388	–	–	0.05%	278
2024 Q3	$236K	Buy	+2,388	New	+$235K	0.06%	257
2023 Q4	–	Sell	-2,878	Closed	-$210K	–	271
2023 Q3	$210K	Sell	2,878 -174	-6%	-$13.9K	0.07%	219
2023 Q2	$254K	Sell	3,052 -440	-13%	-$36.8K	0.08%	195
2023 Q1	$266K	Buy	3,492 +556	+19%	+$46.1K	0.09%	180
2022 Q4	$244K	Buy	+2,936	New	+$238K	0.09%	196
2022 Q2	–	Sell	-2,268	Closed	-$203K	–	229
2022 Q1	$203K	Buy	+2,268	New	+$209K	0.07%	218
2021 Q4	–	Sell	-1,970	Closed	-$262K	–	227
2021 Q3	$262K	Hold	1,970	–	–	0.1%	179
2021 Q2	$253K	Sell	1,970 -73	-4%	-$9.6K	0.1%	179
2021 Q1	$303K	Hold	2,043	–	–	0.13%	152
2020 Q4	$287K	Buy	+2,043	New	+$262K	0.13%	156
2019 Q3	–	Sell	-1,676	Closed	-$147K	–	619
2019 Q2	$147K	Hold	1,676	–	–	0.05%	275
2019 Q1	$152K	Hold	1,676	–	–	0.09%	168
2018 Q4	$120K	Buy	+1,676	New	+$135K	0.08%	184

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

Essex Savings Bank's XBI Position: Q2 2026 in Review

Essex Savings Bank opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 1,312 shares worth $208K. The stake represents 0.04% of the portfolio and ranks #308 among its holdings. This is a return to the name: Essex Savings Bank previously reported a position in XBI as recently as Q1 2025.

Essex Savings Bank first reported a position in XBI in Q4 2018 and has held it in 16 quarters since. The position peaked at $303K in Q1 2021. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Essex Savings Bank held 1,312 shares of State Street SPDR S&P Biotech ETF worth $208K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Essex Savings Bank position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.04% of Essex Savings Bank's portfolio in Q2 2026, its #308 holding.
Essex Savings Bank first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 16 quarters since.
Essex Savings Bank's State Street SPDR S&P Biotech ETF position peaked at $303K in Q1 2021.
551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Essex Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.